255 related articles for article (PubMed ID: 17618838)
1. Association of interleukin-8 polymorphism and immunoglobulin G anti-toxin A in patients with Clostridium difficile-associated diarrhea.
Jiang ZD; Garey KW; Price M; Graham G; Okhuysen P; Dao-Tran T; LaRocco M; DuPont HL
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):964-8. PubMed ID: 17618838
[TBL] [Abstract][Full Text] [Related]
2. Association between IgG2 and IgG3 subclass responses to toxin A and recurrent Clostridium difficile-associated disease.
Katchar K; Taylor CP; Tummala S; Chen X; Sheikh J; Kelly CP
Clin Gastroenterol Hepatol; 2007 Jun; 5(6):707-13. PubMed ID: 17544998
[TBL] [Abstract][Full Text] [Related]
3. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.
Kyne L; Warny M; Qamar A; Kelly CP
N Engl J Med; 2000 Feb; 342(6):390-7. PubMed ID: 10666429
[TBL] [Abstract][Full Text] [Related]
4. A common polymorphism in the interleukin 8 gene promoter is associated with Clostridium difficile diarrhea.
Jiang ZD; DuPont HL; Garey K; Price M; Graham G; Okhuysen P; Dao-Tran T; LaRocco M
Am J Gastroenterol; 2006 May; 101(5):1112-6. PubMed ID: 16573784
[TBL] [Abstract][Full Text] [Related]
5. [Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods].
Altindiş M; Usluer S; Ciftçi H; Tunç N; Cetinkaya Z; Aktepe OC
Mikrobiyol Bul; 2007 Jan; 41(1):29-37. PubMed ID: 17427550
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and clinical features of Clostridium difficile-associated diarrhea in a tertiary hospital in northern Taiwan.
Hsu MS; Wang JT; Huang WK; Liu YC; Chang SC
J Microbiol Immunol Infect; 2006 Jun; 39(3):242-8. PubMed ID: 16783456
[TBL] [Abstract][Full Text] [Related]
7. Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI).
Leav BA; Blair B; Leney M; Knauber M; Reilly C; Lowy I; Gerding DN; Kelly CP; Katchar K; Baxter R; Ambrosino D; Molrine D
Vaccine; 2010 Jan; 28(4):965-9. PubMed ID: 19941990
[TBL] [Abstract][Full Text] [Related]
8. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.
Aseeri M; Schroeder T; Kramer J; Zackula R
Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653
[TBL] [Abstract][Full Text] [Related]
9. The safety of whey protein concentrate derived from the milk of cows immunized against Clostridium difficile.
Young KW; Munro IC; Taylor SL; Veldkamp P; van Dissel JT
Regul Toxicol Pharmacol; 2007 Apr; 47(3):317-26. PubMed ID: 17293018
[TBL] [Abstract][Full Text] [Related]
10. [Clostridium difficile toxin A and other enteropathogens in stool specimens of children hospitalized due to acute diarrhoea].
Rozkiewicz D; Zaremba ML; Fiedoruk K; Daniluk T; Sciepuk M; Kurzatkowska B; Sulik A; Ołdak E
Przegl Epidemiol; 2005; 59(3):711-21. PubMed ID: 16433313
[TBL] [Abstract][Full Text] [Related]
11. Human antibody response to surface layer proteins in Clostridium difficile infection.
Drudy D; Calabi E; Kyne L; Sougioultzis S; Kelly E; Fairweather N; Kelly CP
FEMS Immunol Med Microbiol; 2004 Jul; 41(3):237-42. PubMed ID: 15196573
[TBL] [Abstract][Full Text] [Related]
12. Specific risk factors for Clostridium difficile-associated diarrhea: a prospective, multicenter, case control evaluation.
Vesta KS; Wells PG; Gentry CA; Stipek WJ
Am J Infect Control; 2005 Oct; 33(8):469-72. PubMed ID: 16216661
[TBL] [Abstract][Full Text] [Related]
13. Absence of pseudomembranes in Clostridium difficile-associated diarrhea in patients using immunosuppression agents.
Nomura K; Fujimoto Y; Yamashita M; Morimoto Y; Ohshiro M; Sato K; Oyake T; Kowata S; Konishi H; Yoshikawa T; Ishida Y; Taniwaki M;
Scand J Gastroenterol; 2009; 44(1):74-8. PubMed ID: 18781540
[TBL] [Abstract][Full Text] [Related]
14. Clinical correlation of toxin and common antigen enzyme immunoassay testing in patients with Clostridium difficile disease.
Lee SD; Turgeon DK; Ko CW; Fritsche TR; Surawicz CM
Am J Gastroenterol; 2003 Jul; 98(7):1569-72. PubMed ID: 12873579
[TBL] [Abstract][Full Text] [Related]
15. Comparison of clinical, microbiologic, and clinicopathologic findings in horses positive and negative for Clostridium difficile infection.
Ruby R; Magdesian KG; Kass PH
J Am Vet Med Assoc; 2009 Mar; 234(6):777-84. PubMed ID: 19284345
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of Clostridium difficile-associated diarrhea in a Peruvian tertiary care hospital.
Garcia C; Samalvides F; Vidal M; Gotuzzo E; Dupont HL
Am J Trop Med Hyg; 2007 Nov; 77(5):802-5. PubMed ID: 17984329
[TBL] [Abstract][Full Text] [Related]
17. Clostridium difficile-associated diarrhea and chronic renal insufficiency.
Yousuf K; Saklayen MG; Markert RJ; Barde CJ; Gopalswamy N
South Med J; 2002 Jul; 95(7):681-3. PubMed ID: 12144071
[TBL] [Abstract][Full Text] [Related]
18. [The frequency of Clostridium difficile toxin in neutropenic and non-neutropenic patients with antibiotic-associated diarrhea and analysis of the risk factors].
Tunçcan OG; Ulutan F; Karakuş R
Mikrobiyol Bul; 2008 Oct; 42(4):573-83. PubMed ID: 19149078
[TBL] [Abstract][Full Text] [Related]
19. Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands.
Goorhuis A; Van der Kooi T; Vaessen N; Dekker FW; Van den Berg R; Harmanus C; van den Hof S; Notermans DW; Kuijper EJ
Clin Infect Dis; 2007 Sep; 45(6):695-703. PubMed ID: 17712752
[TBL] [Abstract][Full Text] [Related]
20. Clostridium difficile-associated diarrhea in heart transplant recipients: is hypogammaglobulinemia the answer?
Muñoz P; Giannella M; Alcalá L; Sarmiento E; Fernandez Yañez J; Palomo J; Catalán P; Carbone J; Bouza E
J Heart Lung Transplant; 2007 Sep; 26(9):907-14. PubMed ID: 17845929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
